RBC Capital Sticks to Its Buy Rating for Sartorius Stedim Biotech (0RG8)
RBC Capital analyst Charles Weston maintained a Buy rating on Sartorius Stedim Biotech (0RG8 – Research Report) today and set a price target of ...
FEPI: A Simple Yet Effective Covered-Call Fund For The Current Market Conditions
FEPI ETF's covered-call strategy yielded 15.81% in 10 months. Enjoy tax advantages, steady income, and exposure to large-cap ...
7 Best Vanguard Bond Funds to Buy
On Feb. 11, the firm unveiled two new bond ETFs designed to provide exposure to the short end of the U.S. Treasury yield curve – the Vanguard Ultra-Short Treasury ETF (ticker: VGUS) and the Vanguard 0 ...